Comparable stake leader
HALE DAVID F
SEC ownership of BIOCEPT INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001044378.
Disclosed value leader
HALE DAVID F
Comparable rows
0/15
Latest evidence
17 Nov 2022
- Parsed ownership sources
- 3/4/5
- Largest SEC-reported holder
- HALE DAVID F
- Latest parsed ownership date
- 17 Nov 2022
- Issuer CIK
- 0001044378
- Issuer location
- San Diego, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of BIOCEPT INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HALE DAVID F
Disclosed value leader
HALE DAVID F
Comparable rows
0/15
Latest evidence
17 Nov 2022
3/4/5
Highest disclosed value: $16,311
15 rows are not safely comparable across share classes.
Showing 1-8 of 15 holder rows.
Quick read
HALE DAVID F has the largest disclosed position value at $16.3K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HALE DAVID F's linked filing trail.
Disclosed position value
Top 1
HALE DAVID F
$16.3K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HALE DAVID F |
3/4/5
Director
|
—
class O/S missing
|
$16,311
4,011 shares
|
— | 09 Dec 2021 |
| Samuel D. Riccitelli |
3/4/5
Interim President and CEO, Director
|
—
class O/S missing
|
—
250,000 shares
|
— | 28 Feb 2022 |
| Michael W. Nall |
3/4/5
CEO & President, Director
|
—
mixed-class rows
|
—
180,000 shares
mixed-class rows
|
— | 02 Sep 2021 |
| Antonino Morales |
3/4/5
Interim CFO, Director
|
—
class O/S missing
|
—
150,000 shares
|
— | 28 Feb 2022 |
| Michael C. Dugan |
3/4/5
Chief Med Off & Med. Director
|
—
class O/S missing
|
—
150,000 shares
|
— | 31 Aug 2021 |
| Philippe Marchand |
3/4/5
Chief Operations Officer
|
—
class O/S missing
|
—
150,000 shares
|
— | 31 Mar 2022 |
| Timothy Kennedy |
3/4/5
CFO, COO & Secretary
|
—
class O/S missing
|
—
100,000 shares
|
— | 31 Aug 2021 |
| Michael J. Terry |
3/4/5
Sr VP of Business Development
|
—
class O/S missing
|
—
35,000 shares
|
— | 31 Aug 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 04 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-16 of 16 reporting-owner rows connected to BIOCEPT INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
16
Largest Forms 3/4/5 holder
HALE DAVID F
Net 12M change
$0
Latest report
16 Jun 2023
Recent insider transactions for BIOCEPT INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.